Bavarian Nordic Announces Positive Top Line Results from a

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Bavarian Nordic Announces Positive Top Line Results from a Phase 1 Trial of a Novel, Broad Spectrum RSV Vaccine in Healthy Adult and Elderly Populations
  • Vaccine significantly boosted antibodies and T cells against RSV in the majority of elderly subjects
  • Vaccine induced a  broad immune responses against all RSV subtypes
  • Conference call and webcast today at 8:30 am EDT (2:30 pm CET)

COPENHAGEN, Denmark, May 23, 2016 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced positive top line results from its first-in-man Phase 1 trial of its novel, broad spectrum vaccine for respiratory syncytial virus (RSV). The randomized, placebo-controlled trial, evaluated the safety, tolerability and immunogenicity of the recombinant MVA-BN-based RSV vaccine in 63 healthy adults, ages 18-65.

In the Phase 1 study, subjects were enrolled into three groups to receive two different dose levels of MVA-BN RSV: Low Dose/Adult, High Dose/Adult and High Dose/Elderly. The Elderly group enrolled subjects of 50-65 years of age in order to evaluate the immune responses in a population that is one of the key targets for the vaccine.

MVA-BN RSV was well tolerated, with no unexpected or serious adverse reactions. The vast majority of events represent local and systemic reactions typical for vaccines. A significant boost in antibodies and T cells against RSV was measured in all groups following vaccination with MVA-BN RSV including: 

  • Neutralizing antibodies against both RSV subtypes A & B.
  • In elderly subjects, there was a significant  increase in both blood IgG and IgA antibodies, the latter a specialized antibody that is transported from blood to mucosal surfaces (e.g. nose, throat, lungs).
  • T cell responses against RSV were significantly boosted in elderly subjects vaccinated, with a 3-5 fold increase observed against RSV or the 3 RSV proteins tested to date, including the RSV surface proteins F (fusion) and G (glycoprotein) and the highly conserved nucleocapsid protein (N).
  • The broad T cell response stimulated in the majority of elderly subjects is cross reactive against both RSV subtypes.

Additional data is maturing and is expected to be presented at a later date, including additional T cell data.

"These data suggest the potential of MVA BN RSV to be the first broad spectrum vaccine for RSV, delivering higher rates of protection compared to approaches currently available or in development. While early, these data are highly encouraging, as we have observed a clear dose effect and the ability of the vaccine to stimulate a broad antibody and T cell response to multiple RSV proteins and fully support proceeding into larger Phase 2 clinical studies." said Paul Chaplin, President & Chief Executive Officer of Bavarian Nordic.  "We look forward to initiating Phase 2 in elderly subjects in the second half of 2016, as well as a Phase 1 trial in pediatric subjects in 2017."

MVA-BN RSV is a vaccine candidate specifically designed to target 5 different RSV proteins to ensure a broad immune response against both RSV subtypes (A & B). Extensive preclinical studies had shown that MVA-BN RSV induced a balanced immune response comprised of both antibodies and T cells, in a similar fashion to the natural response to an RSV infection.

Conference call and webcast The management of Bavarian Nordic will host a conference call today at 2:30 pm CET (8:30 am EDT) to discuss the results followed by a Q&A session. Dial-in numbers for the conference call are: Denmark: +45 38 32 28 69, UK+44(0)20 3427 1911, USA: +1 212 444 0896. Participant code is 5110884. A live and archived webcast of the call and relevant slides will be available at http://www.bavarian-nordic.com/investor/event...event=4830 .

About Bavarian Nordic Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases, based on the Company's live virus vaccine platform. Through long-standing collaborations, including a collaboration with the U.S. government, Bavarian Nordic has developed a portfolio of vaccines for infectious diseases, including the non-replicating smallpox vaccine, IMVAMUNE ® , which is stockpiled for emergency use by the United States and other governments. The vaccine is approved in the European Union (under the trade name IMVANEX ® ) and in Canada. Bavarian Nordic and its partner Janssen are developing an Ebola vaccine regimen, which has been fast-tracked, with the backing of worldwide health authorities, and a vaccine for the prevention and treatment of HPV. Additionally, in collaboration with the National Cancer Institute, Bavarian Nordic has developed a portfolio of active cancer immunotherapies, including PROSTVAC ® , which is currently in Phase 3 clinical development for the treatment of advanced prostate cancer. The company has partnered with Bristol-Myers Squibb for the potential commercialization of PROSTVAC. For more information visit www.bavarian-nordic.com or follow us on Twitter @bavariannordic .

Forward-looking statements This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law.

Contacts Rolf Sass Sørensen Vice President Investor Relations (EU) Tel: +45 61 77 47 43

Seth Lewis Vice President Investor Relations (US) Tel: +1 978 341 5271 

Company Announcement no. 17 / 2016

HUG#2014463

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stanford Forum Puts Industrial AI in the Real World

Updated Category News Views 166

Factory Data Is Not a Free Lunch A factory dataset is worth precisely nothing if its owner cannot control it. That was the hard-nosed thread running through the ASI City Forum at Stanford on November 17: industrial AI is not just about smarter models or splashy chip announcements. It is about whether manufacturers will trust a system with proprietary operating data,...

Continue Reading
Rox Taps Dynamics 365 Without Forcing a CRM Reset Yet

Updated Category News Views 129

Enterprise software buyers hate renovations when a useful extension will do. Rox’s new integration with Microsoft Dynamics 365 Sales, announced November 19, 2026, is built around that unglamorous but very real fact. The company is not asking a Global 2000 sales organization to rip out its customer system, retrain everybody, and pray an AI layer somehow pays for the...

Continue Reading
Carbonization Furnaces Turn Waste Rules Into Demand

Updated Category News Views 112

Smoke has become an expensive habit for farmers, mills, and municipalities. That is the real commercial backdrop for carbonization furnaces, not some glossy green-tech slogan. MarketsandMarkets estimates this small global equipment market at $310 million in 2026 and projects $510 million by 2031, a 10.2% compound annual growth rate. For a capital-equipment niche, that is...

Continue Reading
Software-Defined Cars Put $310 Billion in Play by 2035

Updated Category News Views 111

Cars are becoming rolling computers, and that changes who gets paid. Market Growth Reports projects the software-defined vehicle market will rise from $56.94 billion to $310.46 billion by 2035, a 20.74% compound annual growth rate. That is a loud number, no question. Still, investors ought to treat any long-range market forecast like a map, not a mortgage deed. The...

Continue Reading
NYSE Message Record Puts Market Plumbing Into Focus

Updated Category News Views 120

A trillion messages is not a cute little exchange statistic; it is the sort of number that tells you whether the market’s pipes can keep working when everybody starts shouting at once. NYSE says it handled a record 1.166 trillion messages in one day on November 5, roughly 4% above the prior high set amid April 2025 volatility. Better yet, according to the exchange,...

Continue Reading
Minno Bets on Listener Kids to Build Premium Growth

Updated Category News Views 131

Children’s media rarely gets a clean strategic move, but this one comes pretty close. Minno has signed a worldwide, multi-year agreement making it the exclusive faith-based streaming home for Listener Kids’ video library, while commissioning 66 new episodes for its own service. For a company trying to build a serious Christian family-media business, that is more than...

Continue Reading
Blast Doubles Athabasca Ground, but Drills Still Matter

Updated Category News Views 75

More ground in Athabasca can wake up a uranium junior fast, and Blast Resources has certainly grabbed investors’ attention with this one. The company has optioned eight additional uranium claims beside its Wales Lake property in northern Saskatchewan, taking its regional footprint from 12,150 hectares across 16 claims to 30,732 hectares across 24 claims. That is more...

Continue Reading
Ajman Media Forum Puts Trust Ahead of AI Speed in 2026

Updated Category News Views 199

Algorithms may manufacture a flood of words, but they cannot inherit accountability. That was the sensible nerve running through Ajman Media Forum 2026, “The Signal,” inaugurated on November 19 by His Highness Sheikh Ammar bin Humaid Al Nuaimi, Crown Prince of Ajman and Chairman of the Executive Council. For all the fanfare that usually surrounds artificial...

Continue Reading
Trip.com Sets December 1 Date for Third-Quarter Results

Updated Category News Views 122

December’s first after-hours session will put Trip.com Group back under the market’s microscope, whether anybody is ready or not. The company says it will report results for the three months ended September 30, 2026 after the U.S. market closes on Tuesday, December 1. That is the whole hard-news payload for now: a reporting date, a call time, and no numbers to get...

Continue Reading
Live Nation Tests Creator Content With Morgan Jay Series

Updated Category News Views 157

A comedian turning crowd work into songs is hardly a boardroom event, but this one has a useful wrinkle: Live Nation Studios put financing behind it. Morgan Jay and Austin-based agency Hello Party launched Music Therapy with Morgan Jay on YouTube on November 18, with Kam Patterson opening the season. The show pairs Jay and celebrity guests for loose conversation,...

Continue Reading

Top 5 Most Recently Viewed Articles

BlueVoyant Launches Innovative Cybersecurity Solution for Enterprises

Updated Category News Views 249

BlueVoyant Introduces a Cutting-Edge Cybersecurity Solution BlueVoyant has launched its Continuous Optimization for Microsoft Security (COMS) service, marking a significant step in enterprise cybersecurity. This innovative solution is crafted to empower organizations with advanced threat detection and optimization strategies for Microsoft Security tools. Clients benefit...

Continue Reading
Prudential Advisors Welcomes New Talent and Grows Nationally

Updated Category News Views 224

Prudential Advisors' Remarkable Growth in 2025 Prudential Advisors is on an exciting journey, having welcomed an impressive wave of experienced financial advisors, significantly bolstering their national influence. Incorporating skilled advisors managing an astounding $3 billion in client assets marks a pivotal milestone for the firm. With nearly a 9% rise in advisor...

Continue Reading
Investors Unite: Solaris Energy Faces Class Action Lawsuit

Updated Category News Views 351

Understanding the Class Action Lawsuit Against Solaris Energy Infrastructure Recent developments have brought attention to Solaris Energy Infrastructure, Inc. and its ongoing class action lawsuit. Shareholders are encouraged to stand up for their rights as allegations arise concerning the company's practices and communications with investors. Details of the Allegations...

Continue Reading
Raising Awareness for Emergency Notification System Signs

Updated Category News Views 145

Understanding Emergency Notification System Signs As part of an ongoing effort to enhance safety at railroad crossings, Operation Lifesaver, Inc. (OLI), an esteemed national nonprofit dedicated to rail safety education, is launching its inaugural Emergency Notification System (ENS) Sign Awareness Day. This event is not just a one-time notice; it's an encouragement for all...

Continue Reading
Veolia and Mistral AI Unite to Transform Ecological Management

Updated Category News Views 361

Revolutionizing Resource Management with Generative AI Veolia, a prominent name in ecological transformation, is making waves by collaborating with Mistral AI, a leader in generative artificial intelligence. Their recent strategic partnership aims to redefine the management of industrial sites, focusing on water management, waste recycling, and local energy production....

Continue Reading